Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver
PROTEOMICS · 2023
DOI: 10.1002/pmic.202300043 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2023. Verfasst von Haiying Ran und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Analysis Center, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Lipopolysaccharides, Peroxisome Proliferator-Activated Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lipid droplets (LDs) are multifunctional organelles consisting of a central compartment of non‐polar lipids shielded from the cytoplasm by a phospholipid monolayer. The excessive accumulation of LDs in cells is closely related to the development and progression of many diseases in humans and animals, such as liver‐related and cardiovascular diseases. Thus, regulating the LDs size and abundance is necessary to maintain metabolic homeostasis. This study found that lipopolysaccharide (LPS) stimulation reduced the LDs content in the mouse liver. We tried to explain the possible molecular mechanisms at the broad protein and mRNA levels, finding that inhibition of the peroxisome proliferator‐activated receptors (PPAR) signalling pathway by LPS may be a critical factor in reducing LDs content.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Analysis Center, Army Medical University, Chongqing, China.
- Hepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong Province, China.
ORCID-Profile: Jiangbei Yuan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Ran, H., Sun, W., Wang, L., Wang, X., Yu, H., Chen, J., Liu, F., Chao, Z., Pu, Q., Liu, Y., Zeng, Y., Li, Z., Wan, Y., & Yuan, J. (2023). Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver. PROTEOMICS. https://doi.org/10.1002/pmic.202300043
Vancouver
Ran H, Sun W, Wang L, Wang X, Yu H, Chen J, et al. Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver. PROTEOMICS. 2023. doi:10.1002/pmic.202300043
BibTeX
@article{Ran2023,
author = {Ran, Haiying and Sun, Wei and Wang, Liting and Wang, Xiaoyang and Yu, Haili and Chen, Jiajia and Liu, Fang and Chao, Zhiyin and Pu, Qi and Liu, Yang and Zeng, Youlong and Li, Zhangfu and Wan, Ying and Yuan, Jiangbei},
title = {Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver},
journal = {PROTEOMICS},
year = {2023},
doi = {10.1002/pmic.202300043}
}
EUVIMED